SG Americas Securities LLC Reduces Stock Position in Cardinal Health, Inc. $CAH

SG Americas Securities LLC decreased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 75.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,516 shares of the company’s stock after selling 56,545 shares during the quarter. SG Americas Securities LLC’s holdings in Cardinal Health were worth $2,906,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of CAH. SJS Investment Consulting Inc. grew its holdings in Cardinal Health by 1,363.6% in the third quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock valued at $25,000 after purchasing an additional 150 shares during the last quarter. Jones Financial Companies Lllp boosted its position in shares of Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares in the last quarter. Atlantic Edge Private Wealth Management LLC boosted its position in shares of Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after buying an additional 75 shares in the last quarter. Vermillion & White Wealth Management Group LLC grew its stake in Cardinal Health by 55.0% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock valued at $34,000 after acquiring an additional 71 shares during the last quarter. Finally, NewSquare Capital LLC increased its holdings in Cardinal Health by 100.0% during the 2nd quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock valued at $36,000 after acquiring an additional 107 shares in the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on CAH shares. UBS Group upped their price target on shares of Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a report on Friday, October 31st. Evercore ISI upped their target price on Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a research note on Friday, October 31st. Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, October 8th. TD Cowen boosted their price target on Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a report on Monday, November 3rd. Finally, Jefferies Financial Group set a $220.00 price objective on Cardinal Health and gave the company a “buy” rating in a research note on Monday, November 3rd. Fourteen investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $213.40.

Cardinal Health Stock Up 0.7%

CAH stock opened at $202.42 on Tuesday. The stock’s fifty day simple moving average is $204.29 and its 200-day simple moving average is $173.48. Cardinal Health, Inc. has a 52-week low of $119.25 and a 52-week high of $214.93. The stock has a market capitalization of $48.10 billion, a price-to-earnings ratio of 30.53, a price-to-earnings-growth ratio of 1.46 and a beta of 0.65.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The company had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health’s revenue for the quarter was up 22.4% on a year-over-year basis. During the same quarter last year, the business earned $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be given a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s payout ratio is 30.77%.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.